Biochemistry

Chronic diseases such as diabetes are on the rise and are costly and challenging to treat. Whitehead Institute Member Richard Young and colleagues have discovered a common denominator driving these diverse diseases, which may prove to be a promising therapeutic target: proteolethargy, or reduced protein mobility, in the presence of oxidative stress.

Researchers in Whitehead Institute Member Richard Young’s lab and colleagues at MIT show that a machine learning model can predict which subcellular compartments a drug will concentrate in based on its chemical features. This could be used to design safer and more effective drugs, and to understand how subcellular compartments govern diverse biochemical processes.